Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.3440
-0.0185 (-5.10%)
At close: Jun 27, 2025, 4:00 PM
0.3400
-0.0040 (-1.16%)
After-hours: Jun 27, 2025, 5:13 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $14.32 million as of June 27, 2025. Its market cap has decreased by -77.35% in one year.
Market Cap
14.32M
Enterprise Value
-40.06M
1-Year Change
-77.35%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $14.32M, a decrease of -96.47%. That is a compound annual growth rate of -57.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 15.09M | -62.12% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |